Preliminary Programme

1st World NET Forum

Hybrid Event, 8 - 9 March 2022, in Barcelona, Spain

World NET Forum in 2022

ENETS has worked together with our partner NET societies around the world (incl. NANETS, APNETS, COMMNETS, CSNET, CNETS, JNETS, Argentum, NET Initiatives in South America, and INCA) on a first-class scientific programme aimed at bringing the leading scientists in the field of neuroendocrine neoplasms together to connect and inspire clinicians and scientists at the cutting edge of NET research.

Please look at the preliminary programme below.

Become an ENETS member today and benefit from the best conference fee.

For our 19^th Annual ENETS Conference and the 1^st World NET Forum in 2022, ENETS will offer up to 20 travel grants for physicians and scientists with a particular interest in neuroendocrine neoplasms. Travel grants will be awarded to scientists who have submitted outstanding abstracts in basic, translational, and clinical science.

Apply for one of 20 Travel Grants offered in 2022

Preliminary Programme

8 - 9 March 2022 - Hybrid Event

Welcome

Time: Wednesday 11:00 - 11:10

Session 1: Models in NET research

Time: Tuesday 11:10 - 12:20

11:10 - 11:40 Keynote address: An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping

11:40 - 12:00 Talk 1: State-of-the-art NET tumor models: Present & future

12:00 - 12:20 Discussion

Coffee break

Time: Tuesday 12:20 - 12:50

Session 2: NET tumor biology advances

Time: Tuesday 12:50 - 14:45

12:50 - 13:20 Keynote address: Understanding tumor biology of NEN by integrated genomic analysis

13:20 - 13:30 Discussion

13:30 - 13:45 Talk 1: Epigenetic control of human intestinal neuroendocrine cell differentiation

13:45 - 13:55 Discussion

13:55 - 14:10 Talk 2: Immune and stromal heterogeneity associated with cellular origin and cancer evolution in GEP-NET

14:10 - 14:20 Discussion

14:20 - 14:35 Talk 3: Mechanisms of RB loss in neuroendocrine carcinoma

14:35 - 14:45 Discussion

Summary of the day

Time: Tuesday 14:45 - 15:00

Welcome

Time: Wednesday 11:00 - 11:10

Session 3: Therapeutic advances in NET

Time: Wednesday 11:10 - 12:40

11:10 - 11:40 Keynote address: Deciphering NET tumor invasiveness to potentiate real therapy candidates

11:40 - 11:50 Discussion

11:50 - 12:05 Talk 1: From genomics to functional genomics: The discovery and targeting of ATRX and MEN1 mutations in PanNETs

12:05 - 12:15 Discussion

12:15 - 12:30 Talk 2: Mechanisms of resistance to PRRT and overcoming these

12:30 - 12:40 Discussion

Coffee break

Time: Wednesday 12:40 - 13:10

Session 4: Novel areas in NET diagnostic and therapy

Time: Wednesday 13:10 - 14:40

13:10 - 13:40 Keynote address: Precision oncological approach in neuroendocrine tumors (lessons from NET and other cancers)

13:40 - 13:50 Discussion

13:50 - 14:05 Talk 1: New radionuclides for improved diagnosis and therapy in NET

14:05 - 14:15 Discussion

14:15 - 14:30 Talk 2: CAR-T cell technology

14:30 - 14:40 Discussion

Summary of the day

Time: Wednesday 14:40 - 14:55

Closing comments

Time: Wednesday 14:55 - 15:05